“Benefits and Risks of Testosterone Treatment for Hypoactive Sexual Desire Disorder in Women: A Critical Review of Studies Published in the Decades Preceding and Succeeding the Advent of Phosphodiesterase Type 5 Inhibitors”. Clinics, vol. 69, no. 4, Apr. 2014, pp. 294-03, https://doi.org/10.1590/clin.v69i4.79512.